首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1899732

胰岛素帮浦市场规模、份额和成长分析（按类型、组件、疾病适应症、治疗方法、使用类型、患者人口统计特征、通路和地区划分）—2026-2033年行业预测

Insulin Pump Market Size, Share, and Growth Analysis, By Type, By Component, By Disease Indication, By Type of Therapy, By Usage Type, By Patient Demographics, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球胰岛素帮浦市场规模将达到 60.5 亿美元，到 2025 年将达到 65.5 亿美元，到 2033 年将达到 123.2 亿美元，预测期（2026-2033 年）的复合年增长率为 8.22%。

全球胰岛素帮浦市场正经历显着成长，这主要得益于糖尿病（尤其是第1型糖尿病）盛行率的不断上升以及人们对糖尿病管理意识的日益增强。携带式胰岛素输注系统需求的激增主要归功于技术进步，特别是利用人工智慧（AI）和机器学习技术的智慧胰岛素帮浦的研发，这些技术能够改善患者体验和治疗效果。医疗成本的上涨和医疗服务可近性的提高也推动了先进胰岛素帮浦的普及，进一步促进了该产业的扩张。随着越来越多的患者被诊断出患有糖尿病，对有效管理方案的需求持续增长，预计胰岛素帮浦市场将在这个不断变化的医疗环境中保持强劲成长。

全球胰岛素帮浦市场驱动因素

全球胰岛素帮浦市场正经历显着成长，这主要得益于製造商对创新产品研发的重视。糖尿病患者对胰岛素帮浦的接受度不断提高，无论是在已开发国家还是开发中国家，都是推动这一趋势的关键因素。此外，多项临床试验表明，与每日多次注射（MDI）疗法相比，胰岛素帮浦疗法能够显着改善第二型糖尿病患者的血糖控制。这些改善患者预后的证据激励各公司进一步改进产品，并拓展产品线，以满足日益增长的先进糖尿病管理解决方案的需求。

全球胰岛素帮浦市场限制因素

全球胰岛素帮浦市场成长受多种因素制约，其中最主要的是病患对健保报销体系的依赖。许多患者面临健保报销选择有限和胰岛素帮浦高成本，这成为他们接受治疗的障碍。这些经济障碍不仅影响那些寻求有效管理自身健康状况的患者，也可能减缓整个市场的扩张。因此，消除这些经济障碍对于改善患者获得胰岛素帮浦的途径以及推动产业成长至关重要。

全球胰岛素帮浦市场趋势

全球胰岛素帮浦市场正经历一场重大变革，其驱动力在于智慧技术（尤其是人工智慧 (AI)）的融合，旨在提升糖尿病管理的效率。糖尿病盛行率的不断攀升，推动了对能够实现治疗方案自动化和个人化的先进胰岛素输注系统的需求。医疗设备製造商正大力投资于人工智慧赋能的胰岛素泵，以期改善患者的治疗效果，并推动智慧医疗解决方案的转型。这一增长表明，2 型糖尿病患者对胰岛素帮浦的接受度正在不断提高，这将进一步促进医疗资讯科技领域的市场成长和创新。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic
Tandem Diabetes Care
Insulet Corporation
Ypsomed
Roche Diabetes Care
Beta Bionics Inc.
Medtrum Technologies
B. Braun Melsungen AG
Sooil Development Co. Ltd.
Sequel Med Tech, LLC
Jiangsu Delfu Co., Ltd.
ViCentra BV
MicroTech Medical
PharmaSens
Microport Scientific
Debiotech SA

结论与建议

简介目录

Product Code: SQMIG35A2135

Global Insulin Pump Market size was valued at USD 6.05 Billion in 2024 and is poised to grow from USD 6.55 Billion in 2025 to USD 12.32 Billion by 2033, growing at a CAGR of 8.22% during the forecast period (2026-2033).

The global Insulin Pump Market is experiencing significant growth driven by the increasing prevalence of diabetes, especially type 1 diabetes, and a heightened awareness of diabetes management. This surge in demand for portable insulin delivery systems is largely attributed to advancements in technology, particularly the development of smart pumps utilizing artificial intelligence and machine learning, which enhance patient experience and treatment efficacy. The industry's expansion is further supported by rising healthcare expenditures and improved access to medical facilities, making sophisticated insulin pumps more widely available. As more individuals are diagnosed with diabetes, the need for effective management solutions continues to rise, positioning the Insulin Pump Market for robust growth in response to these evolving healthcare dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pump Market Segments Analysis

Global Insulin Pumps Market is segmented by Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel and region. Based on Type, the market is segmented into Tethered Insulin Pumps, Patch Pumps (Tubeless Pumps), Miniature/Implantable Pumps and Smart Insulin Pumps. Based on Component, the market is segmented into Pump Device, Infusion Set (Cannula & Tubing), Reservoir or Cartridge, Battery and Power Systems and Control System & Software. Based on Disease Indication, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on Type of Therapy, the market is segmented into Conventional Insulin Therapy, Continuous Subcutaneous Insulin Infusion (CSII), Automated Insulin Delivery (AID) or Closed Loop Systems and Hybrid Closed Loop Systems. Based on Usage Type, the market is segmented into Reusable Insulin Pumps and Disposable Insulin Pumps. Based on Patient Demographics, the market is segmented into Pediatric (0-17 years), Adult (18+ years) and Geriatric (65+ years). Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Direct Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pump Market

The Global Insulin Pump market is experiencing significant growth, driven by manufacturers' focus on research and development of innovative products. The increasing acceptance of insulin pumps among diabetic patients in both advanced and developing regions is a key factor propelling this trend. Additionally, various clinical trials have demonstrated notable enhancements in glucose management for type 2 diabetes patients using pump therapy compared to those relying on Multiple Daily Injection (MDI) therapy. This evidence of improved patient outcomes is further motivating companies to refine their offerings and expand their product lines to meet the rising demand for advanced diabetes management solutions.

Restraints in the Global Insulin Pump Market

The growth of the global insulin pump market is hampered by several factors, particularly the reliance on reimbursements for treatment accessibility. Many patients face challenges due to limited reimbursement options and the high costs associated with insulin pumps, which can discourage their adoption. This financial barrier not only affects individuals seeking effective management of their health conditions but may also contribute to a slower overall market expansion. As a result, addressing these economic obstacles is crucial for enhancing patient access to insulin pumps and fostering growth within the industry.

Market Trends of the Global Insulin Pump Market

The global insulin pump market is experiencing a significant transformation driven by the integration of intelligent technologies, particularly artificial intelligence, which enhances diabetes management efficiencies. As diabetes prevalence rises, there is an emerging demand for advanced insulin delivery systems that offer automation and personalization in treatment regimens. Device manufacturers are strategically investing in AI-enabled pumps to facilitate improved patient outcomes, fostering a shift towards smart healthcare solutions. This growing trend signals an increased adoption of insulin pumps among individuals with type 2 diabetes, further propelling market growth and innovation within the healthcare IT landscape.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Insulin Pump Market Size by Type & CAGR (2026-2033)

Market Overview
Tethered Insulin Pumps
Patch Pumps (Tubeless Pumps)
Miniature/Implantable Pumps
Smart Insulin Pumps

Global Insulin Pump Market Size by Component & CAGR (2026-2033)

Market Overview
Pump Device
Infusion Set (Cannula & Tubing)
Reservoir or Cartridge
Battery and Power Systems
Control System & Software (Apps/Monitors)

Global Insulin Pump Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Type 1 Diabetes
Type 2 Diabetes

Global Insulin Pump Market Size by Type of Therapy & CAGR (2026-2033)

Market Overview
Conventional Insulin Therapy
Continuous Subcutaneous Insulin Infusion (CSII)
Automated Insulin Delivery (AID) or Closed Loop Systems
Hybrid Closed Loop Systems

Global Insulin Pump Market Size by Usage Type & CAGR (2026-2033)

Market Overview
Reusable Insulin Pumps
Disposable Insulin Pumps

Global Insulin Pump Market Size by Patient Demographics & CAGR (2026-2033)

Market Overview
Pediatric (0-17 Years)
Adult (18+ Years)
Geriatric (65+ Years)

Global Insulin Pump Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Direct Sales

Global Insulin Pump Market Size & CAGR (2026-2033)

North America (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- US
- Canada
Europe (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Component, Disease Indication, Type of Therapy, Usage Type, Patient Demographics, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diabetes Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beta Bionics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtrum Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sooil Development Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sequel Med Tech, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Delfu Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViCentra B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroTech Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PharmaSens
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microport Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Debiotech S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments